Internal radiation therapy (iRT) is an emerging therapeutic approach based on high-energy radionuclide implants categorized as alpha or beta particles placed directly into the tumor to induce cancer cell damage.
This work focuses on the development of a unique approach for incorporating Î²-emitter yttrium-90 (
